Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Dermacyd Breeze Pocket BR (Lactic Acid)
Dermacyd Breeze Pocket BR · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd Breeze Pocket BR (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd Breeze Pocket BR (Lactic Acid) | DRUG | Dermacyd Breeze Pocket BR (Lactic Acid) during 21 consecutive days |
Inclusion criteria: * Integral skin test in the region; * To use products of the same category; Exclusion criteria: * Lactation or gestation; * Use of anti-inflammatory, anti-histaminic or immunosuppressant drugs; * Cutaneous disease (local or spread) in the evaluation area; * Pathology which may...
Dermacyd Breeze Pocket BR is a small molecule product developed by Sanofi for hygiene use. It is also known as Dermacyd Breeze Pocket BR (Lactic Acid). It has been studied in a Phase 3 trial conducted in Brazil among healthy adult female volunteers.
Dermacyd Breeze Pocket BR has been studied for hygiene use. Its Phase 3 trial enrolled healthy adult female volunteers in Brazil under the condition listed as hygiene. The specific clinical indication has not been publicly disclosed.
Dermacyd Breeze Pocket BR is developed by Sanofi, which trades under the ticker SNY. Sanofi is the sponsor associated with the product's registered clinical development program.
Dermacyd Breeze Pocket BR is in Phase 3 development. It is investigational and is not approved. The program has one completed Phase 3 trial, with no active trials currently listed.
Dermacyd Breeze Pocket BR has been evaluated in one completed Phase 3 trial, NCT00793026, titled Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability. The trial enrolled 30 healthy adult female volunteers in Brazil, was uncontrolled, and was not randomized or double blinded.
Yes. Dermacyd Breeze Pocket BR is also known as Dermacyd Breeze Pocket BR (Lactic Acid). The lactic acid name appears in the title of its completed Phase 3 acceptability trial, NCT00793026, which studied the product in healthy adult female volunteers in Brazil.